Skip to main content

APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]